Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole M McLaughlin

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
CD1d-based combination therapy eradicates established tumors in miceMichele W L Teng, Janelle Sharkey, Nicole M McLaughlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastasesChristopher J Chan, Daniel M Andrews, Nicole M McLaughlin, et al.
Cancer Research|May 10, 2012
Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodiesInge Verbrugge, Jim Hagekyriakou, Leslie L Sharp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2010
CD11c+ dendritic cells and B cells contribute to the tumoricidal activity of anti-DR5 antibody therapy in established tumorsNicole M Haynes, Edwin D Hawkins, Ming Li, et al.
Nature Medicine|September 22, 2009
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumorsFrançois Ghiringhelli, Lionel Apetoh, Antoine Tesniere, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
CD1d-based combination therapy eradicates established tumors in miceMichele W L Teng, Janelle Sharkey, Nicole M McLaughlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastasesChristopher J Chan, Daniel M Andrews, Nicole M McLaughlin, et al.
Cancer Research|May 10, 2012
Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodiesInge Verbrugge, Jim Hagekyriakou, Leslie L Sharp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2010
CD11c+ dendritic cells and B cells contribute to the tumoricidal activity of anti-DR5 antibody therapy in established tumorsNicole M Haynes, Edwin D Hawkins, Ming Li, et al.
Nature Medicine|September 22, 2009
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumorsFrançois Ghiringhelli, Lionel Apetoh, Antoine Tesniere, et al.
Pageof 1